WS
ZSAN

Wedbush Securities’s Zosano Pharma Corporation ZSAN Stock Holding History

Wedbush Securities’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-596
Closed -$68K – 1041
2019
Q2 		$68K Buy
+596
New +$70.5K 0.01% 929

Other funds holding ZSAN

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wedbush Securities's ZSAN Position: Q3 2019 in Review

Wedbush Securities sold out of Zosano Pharma Corporation (ZSAN) in Q3 2019, closing a stake of 596 shares — an estimated $68K sold.

Wedbush Securities first reported a position in ZSAN in Q2 2019 and held it in 1 quarter. The position peaked at $68K in Q2 2019. 22 funds tracked by Wall St. Rank hold ZSAN as of Q3 2019.

  • Wedbush Securities reported no remaining Zosano Pharma Corporation position as of Q3 2019 after selling out during the quarter.
  • Wedbush Securities sold 596 Zosano Pharma Corporation shares in Q3 2019, an estimated $68K.
  • Wedbush Securities first reported a position in Zosano Pharma Corporation in Q2 2019 and held it in 1 quarter.
  • Wedbush Securities's Zosano Pharma Corporation position peaked at $68K in Q2 2019.
  • 22 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2019.

Based on Wedbush Securities's 13F filing for Q3 2019, filed 17 Oct 2019.